Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Peripheral × Bevacizumab × 30 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 30 Carcinoma, Hepatocellular 16 Ovarian Neoplasms 15 Neoplasms 15 Fallopian Tube Neoplasms 13 Endometrial Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Brain Neoplasms 6 Neoplasm Metastasis 5 Liver Neoplasms 5 Breast Neoplasms 5 Glioma 4 Glioblastoma 4 Colonic Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Neoplasms, Nerve Tissue 3 Lung Neoplasms 3 Gastrointestinal Neoplasms 3 Digestive System Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Biliary Tract Neoplasms 3 Peritoneal Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Pancreatic Neoplasms 2 Neoplasms by Site 2 Melanoma 2 Carcinoma, Renal Cell 2

Interventions

Vincristine 2 Prednisone 2 Gemcitabine 2 Cyclophosphamide 2 Biopsy 2 tazemetostat 1 sodium-iodide symporter 1 sintilimab 1 ruxolitinib 1 romidepsin 1 ivarmacitinib 1 etoposide phosphate 1 duvelisib 1 cemiplimab 1 belinostat 1 X-Rays 1 Watchful Waiting 1 Specimen Handling 1 Prednisolone 1 Photons 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Immunoglobulin G 1 Etoposide 1 Doxorubicin 1 Disulfides 1 Dexamethasone 1 Cytarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡